Max Vincent John, Ingrid Simonitsch-Klupp, Johannes Griss, Cora Waldstein, Harald Herrmann, Alexander Gaiger, Karoline V Gleixner, Wolfgang R Sperr, Peter Valent
{"title":"骨髓肥大细胞增多症伴发原发性皮肤滤泡中心淋巴瘤1例。","authors":"Max Vincent John, Ingrid Simonitsch-Klupp, Johannes Griss, Cora Waldstein, Harald Herrmann, Alexander Gaiger, Karoline V Gleixner, Wolfgang R Sperr, Peter Valent","doi":"10.1007/s00277-025-06588-4","DOIUrl":null,"url":null,"abstract":"<p><p>In a subset of patients with systemic mastocytosis (SM), an associated hematologic neoplasm (AHN) is identified. Most AHN are myeloid neoplasms, whereas lymphoid neoplasms are uncommon. We report on a 70-year-old female patient with bone marrow mastocytosis (BMM) associated with primary cutaneous follicle center lymphoma (PCFCL). Initially, the patient had developed BMM at the age of 61 years. Since then, she suffered from recurrent anaphylaxis and vitiligo. A BM investigation revealed several compact aggregates of MC exhibiting CD25 and the KIT mutation D816V. The basal serum tryptase level ranged between 26.0 and 30.9 ng/ml. Nine years after the initial diagnosis of BMM, the patient developed cutaneous nodular reddish lesions on her scalp. Histologic examination excluded mastocytosis and revealed PCFCL. Radiation therapy resulted in regression of cutaneous lesions. This unusual case demonstrates that patients with BMM may develop a lymphoid neoplasm in extramedullary sites, including skin. However, both neoplasms were separable from each other by site and pathology, which would argue for two separate etiologies and against a classical AHN.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bone marrow mastocytosis associated with primary cutaneous follicle center lymphoma: an unusual case report.\",\"authors\":\"Max Vincent John, Ingrid Simonitsch-Klupp, Johannes Griss, Cora Waldstein, Harald Herrmann, Alexander Gaiger, Karoline V Gleixner, Wolfgang R Sperr, Peter Valent\",\"doi\":\"10.1007/s00277-025-06588-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In a subset of patients with systemic mastocytosis (SM), an associated hematologic neoplasm (AHN) is identified. Most AHN are myeloid neoplasms, whereas lymphoid neoplasms are uncommon. We report on a 70-year-old female patient with bone marrow mastocytosis (BMM) associated with primary cutaneous follicle center lymphoma (PCFCL). Initially, the patient had developed BMM at the age of 61 years. Since then, she suffered from recurrent anaphylaxis and vitiligo. A BM investigation revealed several compact aggregates of MC exhibiting CD25 and the KIT mutation D816V. The basal serum tryptase level ranged between 26.0 and 30.9 ng/ml. Nine years after the initial diagnosis of BMM, the patient developed cutaneous nodular reddish lesions on her scalp. Histologic examination excluded mastocytosis and revealed PCFCL. Radiation therapy resulted in regression of cutaneous lesions. This unusual case demonstrates that patients with BMM may develop a lymphoid neoplasm in extramedullary sites, including skin. However, both neoplasms were separable from each other by site and pathology, which would argue for two separate etiologies and against a classical AHN.</p>\",\"PeriodicalId\":8068,\"journal\":{\"name\":\"Annals of Hematology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-09-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00277-025-06588-4\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00277-025-06588-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Bone marrow mastocytosis associated with primary cutaneous follicle center lymphoma: an unusual case report.
In a subset of patients with systemic mastocytosis (SM), an associated hematologic neoplasm (AHN) is identified. Most AHN are myeloid neoplasms, whereas lymphoid neoplasms are uncommon. We report on a 70-year-old female patient with bone marrow mastocytosis (BMM) associated with primary cutaneous follicle center lymphoma (PCFCL). Initially, the patient had developed BMM at the age of 61 years. Since then, she suffered from recurrent anaphylaxis and vitiligo. A BM investigation revealed several compact aggregates of MC exhibiting CD25 and the KIT mutation D816V. The basal serum tryptase level ranged between 26.0 and 30.9 ng/ml. Nine years after the initial diagnosis of BMM, the patient developed cutaneous nodular reddish lesions on her scalp. Histologic examination excluded mastocytosis and revealed PCFCL. Radiation therapy resulted in regression of cutaneous lesions. This unusual case demonstrates that patients with BMM may develop a lymphoid neoplasm in extramedullary sites, including skin. However, both neoplasms were separable from each other by site and pathology, which would argue for two separate etiologies and against a classical AHN.
期刊介绍:
Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.